sec filing
EN
OTC · ENZN
Enzon Pharmaceuticals, Inc.
Healthcare · Biotechnology
$4.71
Up+$0.06 (+1.29%)
Updated Oct 11, 2026, 6:17 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.08M
- P/E ratio
- -3.06
- Dividend yield
- 0.00%
- 52-week range
- $0.09 – $12.99
- Volume
- 1.58K
- Avg. volume
- 53.8K
Price performance · ENZN
ENZN price history
1M range · 0 trading sessions · Daily adjusted prices
ENZN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ENZN news
The latest Smart Investors Daily articles mentioning ENZN.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…